ALLIVAY

Allergan Finance, Llc

Application Filed: 2014-06-20
Trademark Application Details
Trademark Logo ALLIVAY
606
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED
Research OneLook Acronym Finder
Serial Number86315808
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameMatthew O. Brady
Attorney Docket NumberALL002
Law Office AssignedL30
Employee NameSTRINGER, DANIEL S

Timeline

2014-06-20Application Filed
2014-11-25Published for Opposition
2017-11-29Location: TMEG LAW OFFICE 103
2018-07-02Abandon
2018-07-02Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: ALLERGAN FINANCE, LLC
AddressMorris Corporate Center III 400 Interpace Parkway Parsippany NV 07054
Legal Entity TypeLimited Liability Company
Legal Entity StateNV

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MATTHEW O. BRADY
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA, 92612

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2014-06-241 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2014-06-282 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2014-09-243 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN2014-10-014 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED2014-10-015 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2014-10-016 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED2014-10-017 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2014-10-018 CNSA P:
ASSIGNED TO LIE2014-10-229 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED2014-10-2210 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2014-11-0511 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2014-11-2512 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2014-11-2513 NPUB E:E-Mail
EXTENSION OF TIME TO OPPOSE RECEIVED2014-12-2314 ETOF T:TTAB Proceeding
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED2015-04-1015 ETOP T:TTAB Proceeding
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2015-05-2616 NOAM E:E-Mail
TEAS PETITION TO REVIVE RECEIVED2015-12-0317 PROA I:Incoming Correspondence
PETITION TO REVIVE-GRANTED2015-12-0318 PETG O:Outgoing Correspondence
EXTENSION RECEIVED WITH TEAS PETITION2015-12-0319 TPEX I:Incoming Correspondence
NOTICE OF REVIVAL - E-MAILED2015-12-0320 NREV E:E-Mail
CASE ASSIGNED TO INTENT TO USE PARALEGAL2016-01-1721 AITU A:Allowance for Publication
EXTENSION 1 FILED2015-11-2722 EXT1 S:
EXTENSION 1 GRANTED2016-01-2823 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-01-2924 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2016-05-2625 EEXT I:Incoming Correspondence
EXTENSION 2 FILED2016-05-2626 EXT2 S:
EXTENSION 2 GRANTED2016-05-3127 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-06-0128 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2016-10-1929 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2016-10-1930 EXT3 S:
EXTENSION 3 GRANTED2016-10-2731 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-10-2832 EXRA E:E-Mail
TEAS CHANGE OF CORRESPONDENCE RECEIVED2017-01-3033 TCCA I:Incoming Correspondence
TEAS EXTENSION RECEIVED2017-04-2034 EEXT I:Incoming Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2017-04-2635 ASGN I:Incoming Correspondence
EXTENSION 4 FILED2017-04-2036 EXT4 S:
EXTENSION 4 GRANTED2017-04-2737 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-04-2838 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-11-1739 EEXT I:Incoming Correspondence
EXTENSION 5 FILED2017-11-1740 EXT5 S:
EXTENSION 5 GRANTED2017-11-2941 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-11-3042 EXRA E:E-Mail
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2018-01-0343 ASCK I:Incoming Correspondence
ABANDONMENT - NO USE STATEMENT FILED2018-07-0244 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2018-07-0245 MAB6 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed